NCT04138017View on ClinicalTrials.gov

ViviGen Cellular Bone Matrix for Hindfoot or Ankle Arthrodesis

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

April 10, 2023

Study Completion Date

December 1, 2023

Conditions
Ankle DeformityAnkle Arthritis
Interventions
DEVICE

ViviGen

A cellular bone matrix which includes viable osteoblasts within a corticocancellous and demineralized bone carrier, represents a unique alternative to autograft or existing products which utilize mesenchymal stem cells.

Trial Locations (1)

22908

University of Virginia, Charlottesville

Sponsors

Collaborators (1)

DePuy Synthes
All Listed Sponsors
collaborator

DePuy Synthes

INDUSTRY

lead

University of Virginia

OTHER

NCT04138017 - ViviGen Cellular Bone Matrix for Hindfoot or Ankle Arthrodesis | Biotech Hunter | Biotech Hunter